Previous Article in Journal / Special Issue
Genomic Profiling of Laryngeal Squamous Cell Carcinoma Reveals Novel Biomarkers for Precision Medicine
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Somatic Mutational Landscape in Follicular Thyroid Cancer: Insights from AACR GENIE Data

1
School of Medicine-Phoenix, Creighton University, Phoenix, AZ 85012, USA
2
Rutgers Robert Wood Johnson Medical School (RWJMS), New Brunswick, NJ 08901, USA
3
Herbert Wertheim College of Medicine, Miami, FL 33199, USA
4
School of Medicine, Boston University, Boston, MA 02118, USA
5
Carle Illinois College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA
6
School of Medicine, Creighton University, Omaha, NE 68178, USA
7
Division of Pediatric Otolaryngology, Rady Children’s Hospital, San Diego, CA 92123, USA
8
Department of Otolaryngology-Head and Neck Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL 12901, USA
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2026, 16(1), 3; https://doi.org/10.3390/jpm16010003 (registering DOI)
Submission received: 14 November 2025 / Revised: 15 December 2025 / Accepted: 18 December 2025 / Published: 21 December 2025

Abstract

Objective(s): To delineate the somatic mutational landscape of follicular thyroid carcinoma (FTC) from a large, real-world cohort to identify molecular subtypes and actionable targets for personalized therapeutic interventions. Methods: Genomic and clinical data for 168 FTC samples were retrieved from the AACR Project GENIE® registry via cBioPortal. This study assessed mutation frequencies, copy number alterations, and subgroup differences (primary vs. metastatic; adult vs. pediatric) using statistical tests. Results: NRAS was the most common mutation (33.9%), followed by TERT (22.6%), DICER1 (15.5%), HRAS (11.9%), and PTEN (10.7%). DICER1 mutations were significantly enriched in pediatric cases (44.4% vs. 4.6% in adults, p < 0.001), while TERT mutations were exclusive to adults (42%). NRAS mutations were more frequent in metastatic tumors (42.4%) than primary tumors (29.2%). Conclusions: FTC tumorigenesis is driven by distinct molecular pathways, with significant heterogeneity between pediatric and adult patients as well as primary and metastatic disease. These findings underscore the necessity of molecular profiling for patient stratification and provide a strong rationale for developing personalized treatment strategies to improve clinical outcomes.
Keywords: follicular thyroid cancer; somatic mutations; AACR GENIE; NRAS; TERT; DICER1 follicular thyroid cancer; somatic mutations; AACR GENIE; NRAS; TERT; DICER1

Share and Cite

MDPI and ACS Style

Hsia, B.; Kuzniar, J.; Luzarraga, J.; Sure, A.; Veluvolu, V.; Oved, E.; Silberstein, P.T.; Thirumalareddy, J.; Tauseef, A.; Patel, V.; et al. Somatic Mutational Landscape in Follicular Thyroid Cancer: Insights from AACR GENIE Data. J. Pers. Med. 2026, 16, 3. https://doi.org/10.3390/jpm16010003

AMA Style

Hsia B, Kuzniar J, Luzarraga J, Sure A, Veluvolu V, Oved E, Silberstein PT, Thirumalareddy J, Tauseef A, Patel V, et al. Somatic Mutational Landscape in Follicular Thyroid Cancer: Insights from AACR GENIE Data. Journal of Personalized Medicine. 2026; 16(1):3. https://doi.org/10.3390/jpm16010003

Chicago/Turabian Style

Hsia, Beau, Julia Kuzniar, Joey Luzarraga, Asritha Sure, Vinay Veluvolu, Eli Oved, Peter T. Silberstein, Joseph Thirumalareddy, Abubakar Tauseef, Vijay Patel, and et al. 2026. "Somatic Mutational Landscape in Follicular Thyroid Cancer: Insights from AACR GENIE Data" Journal of Personalized Medicine 16, no. 1: 3. https://doi.org/10.3390/jpm16010003

APA Style

Hsia, B., Kuzniar, J., Luzarraga, J., Sure, A., Veluvolu, V., Oved, E., Silberstein, P. T., Thirumalareddy, J., Tauseef, A., Patel, V., & Khaku, A. (2026). Somatic Mutational Landscape in Follicular Thyroid Cancer: Insights from AACR GENIE Data. Journal of Personalized Medicine, 16(1), 3. https://doi.org/10.3390/jpm16010003

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop